Shenzhen Techdow Pharmaceutical Co., Ltd.: Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, P
- Recall status
- Ongoing (still active)
- Severity
- Class II: could cause temporary or reversible health problems What recall classes mean
- Where sold
- Nationwide in the USA.
Common questions
- Is Shenzhen Techdow Pharmaceutical Heparin Sodium Injection USP 5 000 USP Units/mL recalled?
- Yes. FDA (drug) recalled Shenzhen Techdow Pharmaceutical Heparin Sodium Injection USP 5 000 USP Units/mL on 2026-10-28. Recall status: Ongoing (still active).
- What is the hazard?
- Lack of Assurance of Sterility
- Where was it sold?
- Nationwide in the USA.
Read the official notice at FDA (drug) →
Is Shenzhen Techdow Pharmaceutical recalled?
More recalls
- bioQuad Life Sciences: OsteoDenx capsules
- Game Changer Products, LLC: 10 Day Forecast Capsules 3200mg
- Eugia US LLC: Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single
- Trifluent Pharma LLC: Tridacaine III / Lidocaine Patch 5%, 15 envelopes
- MSN Laboratories Private Limited (Formulations Division, Unit-II): Atorvastatin
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Shenzhen Techdow Pharmaceutical Co., Ltd.
- Product
- Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, PA 19047-1885. Carton NDC: NDC 81952-111-06, Vial NDC: 81942-111-01
- Reason / hazard
- Lack of Assurance of Sterility
- What to do (remedy)
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide in the USA.
- Recall initiated
- 2026-10-01
- Code info
- Lot# CU03232A, Exp 1/31/2028
- Product quantity
- 251,000 1 mL multidose vials
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Shenzhen
- Country
- China
- Event id
- 100049
Free daily digest + "My products" watchlist